An overhaul of drug pricing in the US is partly to blame for two companies threatening to pull their products from Australia’s Pharmaceutical Benefits Scheme.
NEWYou can now listen to Fox News articles! PROVO, Utah — A towel and screwdriver recovered during the investigation into…
Descrease article font size Increase article font size Air Canada says it’s cancelling or delaying several flights to some U.S.…
NewsFeedAn Argentina fan waves the Israeli flag during his team’s Round of 16 match against Egypt. Some viewed it as…
An elderly man was lucky to escape with non-life threatening injuries after a horror early morning crash in Denbarker on…
Business
Bitcoin (BTC) continued to weaken on Wednesday as sellers maintained control following the cryptocurrency’s rejection near the $64,000 level. The latest decline extends the ongoing…
Check out the companies making headlines before the bell: Fiserv — The…
Sam Altman ChatGPT AI just circled November on the calendar and put…
The Dow Jones Industrial Average retreated from record levels on Tuesday as…
Politics
NEWYou can now listen to Fox News articles! Texas Gov. Greg Abbott ordered an investigation into a Texas hospital Tuesday…
Tech & Innovation
CNBC’s Jim Cramer said Tuesday felt like a vintage day on Wall Street after Samsung’s earnings sent chip stocks tumbling and megacaps that have lagged for…
